4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics

SparingVision Raises €75 Million Series B

4BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A

4BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science

Ray Therapeutics Receives $4M in Funding from the California Institute for Regenerative Medicine

Code Biotherapeutics Announces Collaboration with Takeda